0

Back to LabQ Clinical 2017: Passively Acquired Red Blood Cell Antibody Reactivity Due to Daratumumab (Transfusion Medicine LQCL1716)
LabQ Clinical 2017: Passively Acquired Red Blood Cell Antibody Reactivity Due to Daratumumab (Transfusion Medicine LQCL1716)

LabQ Clinical 2017: Passively Acquired Red Blood Cell Antibody Reactivity Due to Daratumumab (Transfusion Medicine LQCL1716)

This is an online activity in transfusion medicine that offers 2.0 continuing education (CMLE) credit that can be used to fulfill CMP requirements.

  • List Price: $20.00
  • Member Price: $15.00
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $5.00 or more Join
Item Details:
Intended Audience: Clinical Scientists, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators.

Upon completion of this activity, you will be able to:

  • identify the aliment for which daratumumab treatment has been...
Back to LabQ Clinical 2017: Passively Acquired Red Blood Cell Antibody Reactivity Due to Daratumumab (Transfusion Medicine LQCL1716)
View More View Less

Bought This Bought That ...